1. Koh, D. M., & Collins, D. J. (2007).Diffusion-weighted MRI in the body: Applications and challenges in oncology.

American Journal of Roentgenology, 188(6), 1622–1635.— This review discusses the role of DWI in oncologic imaging, outlining its advantages and challenges in detecting small or subtle lesions, including those in the peritoneum.

2. Brakenhoff, R. H., et al. (2009).Imaging of peritoneal carcinomatosis: CT versus MRI.

Radiographics, 29(3), 753–762.— This article compares CT and MRI in the evaluation of peritoneal carcinomatosis, highlighting the limitations of CT and the benefits of MRI in lesion characterization and staging.

3. Catalano, O., et al. (2014).Diffusion-weighted MRI for the detection of peritoneal metastases: Current applications and future perspectives.

Abdominal Radiology, 39(7), 1371–1380.— Focused on the role of DWI in detecting peritoneal metastases, this paper discusses how diffusion imaging improves lesion detection and staging accuracy in oncologic patients.

4. Khalil, M., et al. (2011).Comparative evaluation of CT and MRI in the assessment of peritoneal carcinomatosis.

Journal of Clinical Oncology, 29(10), 1322–1328.— This study offers a direct comparison between CT and MRI for peritoneal lesion detection and underscores the importance of advanced MRI protocols in accurate staging.

5. Rega, S., et al. (2010).T1 out-of-phase imaging in the detection of fat-containing lesions in the peritoneum: An adjunct in oncologic imaging.

European Journal of Radiology, 76(2), 129–135.— This article details how T1 out-of-phase imaging can enhance the detection of lesions in fat-rich regions, which is particularly relevant for identifying subtle peritoneal deposits.

6. Kim, Y. H., et al. (2011).The added value of diffusion-weighted imaging in the evaluation of peritoneal carcinomatosis.

Journal of Magnetic Resonance Imaging, 33(4), 905–911.